MDPI and ACS Style
Durbajło, A.; Świeżyński, M.; Ziemba, B.; Starzyczny-Słota, D.; Samborska-Plewicka, M.; Cencelewicz-Lesikow, A.; Chrzanowska-Kapica, A.; Dobrzyńska-Rutkowska, A.; Drab-Mazur, I.; Kulma-Kreft, M.;
et al. Prospective, Observational Study of Aflibercept Use in Combination with FOLFIRI in Patients with Metastatic Colorectal Cancer: A Real-World Effectiveness Study. Cancers 2024, 16, 1992.
https://doi.org/10.3390/cancers16111992
AMA Style
Durbajło A, Świeżyński M, Ziemba B, Starzyczny-Słota D, Samborska-Plewicka M, Cencelewicz-Lesikow A, Chrzanowska-Kapica A, Dobrzyńska-Rutkowska A, Drab-Mazur I, Kulma-Kreft M,
et al. Prospective, Observational Study of Aflibercept Use in Combination with FOLFIRI in Patients with Metastatic Colorectal Cancer: A Real-World Effectiveness Study. Cancers. 2024; 16(11):1992.
https://doi.org/10.3390/cancers16111992
Chicago/Turabian Style
Durbajło, Agnieszka, Marcin Świeżyński, Beata Ziemba, Danuta Starzyczny-Słota, Marzena Samborska-Plewicka, Anna Cencelewicz-Lesikow, Agata Chrzanowska-Kapica, Aneta Dobrzyńska-Rutkowska, Iwona Drab-Mazur, Monika Kulma-Kreft,
and et al. 2024. "Prospective, Observational Study of Aflibercept Use in Combination with FOLFIRI in Patients with Metastatic Colorectal Cancer: A Real-World Effectiveness Study" Cancers 16, no. 11: 1992.
https://doi.org/10.3390/cancers16111992